Ledger.Open graph →
SEC Form D · filed July 17, 2015

HLS Therapeutics Inc

Offering
$112.8M
Sold
$112.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CALEDON, Ontario, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Joseph D. Maclean · Caledon, Ontario, CanadaExec · DirectorBill D. Wells · Caledon, Ontario, CanadaDirectorGregory D. Gubitz · Caledon, Ontario, CanadaExec · DirectorChris D. Fibiger · Caledon, Ontario, CanadaExecGilbert D. Godin · Caledon, Ontario, CanadaExec · DirectorSabrina Foster · Grand Cayman, Cayman IslandsExec · DirectorR. S. Mckenzie · MARLBOROUGH, MADirectorAlexander Goulden · Grand Cayman, Cayman IslandsExecStephen Cucchairo · Boston, MAExec · DirectorDavid P. Leatherwood · Sanibel, FLExec · DirectorDavid L. Hall · Baton Rouge, LADirectorChristopher H. Drossos · Baton Rouge, LAExec · DirectorJeffrey B. Bartlam · Baton Rouge, LAExecStephen K. Bowen · Baton Rouge, LAExec · DirectorSteven W. Reints · Baton Rouge, LAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗